초록 ▼

A method for treating or preventing retinal pathology or injury. The method locates and secures a retinal stimulating substance in the eye between the internal limiting membrane and the retina, which is the target site for the substance. The substance may be an implant that provides electrical stimu

A method for treating or preventing retinal pathology or injury. The method locates and secures a retinal stimulating substance in the eye between the internal limiting membrane and the retina, which is the target site for the substance. The substance may be an implant that provides electrical stimulation to adjacent ganglion and neurofiber cells. Alternatively, the substance may be a pharmaceutical substance to stimulate the retina. In addition to providing direct contact of the substance with its target, the method obviates the need for artificial structures such as tacks or adhesives which may cause retinal bleeding or traction.

대표청구항 ▼

What is claimed is: 1. A method for providing a substance to a mammalian eye having an internal limiting membrane, the method comprising: visualizing the internal limiting membrane of the eye; locating the substance between the internal limiting membrane and the retina; and using the internal lim

What is claimed is: 1. A method for providing a substance to a mammalian eye having an internal limiting membrane, the method comprising: visualizing the internal limiting membrane of the eye; locating the substance between the internal limiting membrane and the retina; and using the internal limiting membrane to secure the substance. 2. The method of claim 1 wherein the substance comprises a drug. 3. The method of claim 1 wherein the substance comprises a device. 4. The method of claim 3 wherein the device comprises at least one array for electrostimulation of the retina. 5. The method of claim 4 wherein the device has external connectors. 6. The method of claim 1 wherein the substance is in a delivery vehicle. 7. The method of claim 6 wherein the delivery vehicle is selected from the group consisting of a capsule, a bead, a liposome, a sphere, a dissolvable biocompatible polymer sheet, and combinations thereof. 8. The method of claim 6 wherein the delivery vehicle provides slow-release drug delivery. 9. A method for effecting treatment of a retina in a mammal comprising providing a substance between an internal limiting membrane and the retina to contact the retina and stimulate retinal cells to effect treatment. 10. The method of claim 9 wherein the treatment effected is for a condition selected from the group consisting of retinitis pigmentosa, macular degeneration, a degenerative retinal disease, and combinations thereof. 11. The method of claim 9 wherein the substance comprises at least one semiconductor microphotodiode array. 12. The method of claim 9 wherein the substance comprises at least one electrode array. 13. The method of claim 9 wherein the substance comprises a vehicle containing a drug. 14. The method of claim 13 wherein the drug is selected from the group consisting of an α-adrenergic agonist, a β-adrenergic agonist, an antiinflammatory agent, an antiproliferative agent, and combinations thereof. 15. The method of claim 9 wherein retinal cells stimulated are selected from the group consisting of photoreceptor cells, ganglion cells, neurofiber cells, and combinations thereof. 16. A method for enhancing vision in a patient having decreased vision due to retinal pathology or injury comprising locating a retinal stimulator substance between an internal limiting membrane and the retina, the substance capable of stimulating the retina to enhance visual function. 17. The method of claim 16 wherein the substance comprises a photostimulated semiconductor microphotodiode array. 18. The method of claim 17 further comprising providing a light source to stimulate the array. 19. The method of claim 16 wherein the substance comprises an electrically stimulated electrode array. 20. The method of claim 19 further comprising providing an electrical source to stimulate the array. 21. The method of claim 16 wherein the patient has a retinal pathology selected from the group consisting of retinitis pigmentosa, macular degeneration, a retinal degenerative disease, and combinations thereof. 22. A method for effecting treatment of a retina in a mammal comprising providing retinal chemical stimulator between an internal limiting membrane and the retina to contact the retina and stimulate retinal cells to effect treatment. 23. The method of claim 14 wherein the drug affects retinal degeneration. 24. The method of claim 14 wherein the drug is regenerative. 25. The method of claim 1 wherein the substance comprises a drug and a device. 26. A method for effecting treatment of a retina in a mammal comprising providing at least one connectionless array between an internal limiting membrane and the retina to contact the retina and stimulate retinal cells to effect the treatment. 27. The method of claim 26, wherein the at least one connectionless array comprises at least one photostimulated array. 28. The method of claim 27, wherein the at least one photostimulated array comprises at least one semiconductor microphotodiode array. 29. The method of claim 1, wherein the substance comprises at least one connectionless array. 30. The method of claim 29, wherein the at least one connectionless array comprises at least one photostimulated array. 31. The method of claim 30, wherein the at least one photostimulated array comprises at least one semiconductor microphotodiode array.